SCHEMBL220417

SCHEMBL220417

CC(C)CC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10837789 0.77 CYP2C19 (0.35)
SCHEMBL11276757 0.74 CYP2C19 (0.33)
SCHEMBL4429855 0.74
SCHEMBL11274187 0.74
SCHEMBL10838093 0.74
SCHEMBL6551747 0.72
SCHEMBL22326984 0.72
SCHEMBL8304550 0.72
SCHEMBL18899943 0.72 CYP2C19 (0.32)
SCHEMBL621376 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114247476-A Zirconium-based catalytic system and method for preparing linear alpha-olefin by catalyzing ethylene oligomerization through zirconium-based catalytic system 北京化工大学 2022-03-29 CN claimed
EP-3752496-A1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES, INC. (US) 2020-12-23 EP claimed
CN-109134716-B Vanadium catalyst and method for preparing olefin polymer 北京引发科技有限公司 2020-11-10 CN claimed
WO-2019161280-A1 METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION GILEAD SCIENCES, INC. (US) 2019-08-22 WO claimed
WO-2024121367-A1 NOVEL SUBSTITUTED PYRAZINE-CARBOXAMIDE-IMIDAZOPYRIDINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-06-13 WO disclosed
WO-2024010823-A1 SYSTEM AND METHOD FOR MULTI-GAS SENSING AT A SINGLE OPERATING TEMPERATURE GENERAL ELECTRIC COMPANY (US) 2024-01-11 WO disclosed
EP-4157827-A1 IL-17A MODULATORS SANOFI (FR) 2023-04-05 EP disclosed
EP-4157452-A1 COMPOSITIONS AND METHODS FOR TREATING COCAINE, NICOTINE, AND METHAMPHETAMINE DEPENDENCE Behnam, Babak (US) 2023-04-05 EP disclosed
EP-4010341-A1 TRKB POSITIVE ALLOSTERIC MODULATORS Université de Strasbourg (FR) 2022-06-15 EP disclosed
EP-4010339-A1 HERBICIDAL AMIDES BASF SE (DE) 2022-06-15 EP disclosed
CN-114247476-A Zirconium-based catalytic system and method for preparing linear alpha-olefin by catalyzing ethylene oligomerization through zirconium-based catalytic system 北京化工大学 2022-03-29 CN disclosed
EP-3927698-A1 AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2021-12-29 EP disclosed
EP-0325397-B1 DIUREA DERIVATIVES USEFUL AS MEDICAMENTS AND PROCESSES FOR THE PREPARATION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-08-18 EP disclosed
US-5227492-A Anticholesterol agents YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1993-07-13 US disclosed
WO-1993003344-A2 HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR IMMUNOASSAYS FOR PROPOXYPHENE ABBOTT LABORATORIES (US) 1993-02-18 WO disclosed
US-5166429-A Enzyme inhibitors of acylcoenzyme A cholesterol transferase as anticholesterol agents or antideposit agents YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-11-24 US disclosed
US-5091419-A Anticholesterol agent YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1992-02-25 US disclosed
EP-0347931-A2 Polypeptide comprising repeated cell-adhesive core sequences Azuma, Ichiro (JP) 1989-12-27 EP disclosed
EP-0325397-A1 Diurea derivatives useful as medicaments and processes for the preparation thereof YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1989-07-26 EP disclosed
US-4154830-A ANTIBIOTICS, BACTERICIDES FOR INFECTIONS CARLO ERBA S.P.A. (IT) 1979-05-15 US disclosed